MIR1281: A Drug Target / Disease Biomarker (G100302237)
MIR1281: A Drug Target / Disease Biomarker
MIR1281, also known as interleukin-128 (IL-128), is a protein that is expressed in a variety of tissues throughout the body, including the immune system, skin, and hair. It is a cytokine, which means it is a protein that is produced by the immune system in response to the presence of foreign substances in the body.
One of the things that makes MIR1281 such a potential drug target is its role in the immune response. MIR1281 has been shown to play a key role in the regulation of T cell development and function. T cells are a type of immune cell that play a critical role in protecting the body against infection and disease. MIR1281 has been shown to regulate the production of T cells by suppressing the activity of a protein called T-cell factor (T-CF).
Another potential drug target for MIR1281 is its role in skin health. MIR1281 has been shown to play a key role in the regulation of skin cell growth and differentiation. It has been shown to reduce the production of a protein called melanin by suppressing the activity of a protein called melanoma-associated protein 6 (MAP-6). MAP-6 is a transcription factor that has been shown to play a key role in the regulation of skin color.
MIR1281 may also be a potential biomarker for some diseases. For example, it has been shown to be elevated in the blood of people with multiple sclerosis, a disease in which the immune system attacks the central nervous system. It has also been shown to be elevated in the blood of people with rheumatoid arthritis, a disease in which the immune system attacks the joints.
In conclusion, MIR1281 is a protein that has been shown to play a key role in the immune response and skin health. As a result, it may be a promising drug target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of MIR1281 in the immune system and skin health, and to determine its potential as a drug.
Protein Name: MicroRNA 1281
The "MIR1281 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1281 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1
